Department of Medicine, Mount Auburn Hospital, Harvard Medical School, 330 Mt Auburn St, Cambridge, MA, USA.
Section Endocrinology, Diabetes, Nutrition and Weight Management, Department of Medicine, Boston University School of Medicine, Boston, MA, USA.
Arch Osteoporos. 2021 Nov 13;16(1):171. doi: 10.1007/s11657-021-01026-0.
Multiple observational studies have reported high prevalence of fracture in patients with thalassemia. However, most of these studies have included limited number of patients, and only few of them have reported prevalence of fracture among patients with different types and severity of thalassemia.
This systematic review and meta-analysis was conducted to summarize all available data of fracture prevalence among patients with thalassemia.
A systematic review was conducted using EMBASE and MEDLINE databases from inception to June 2021 to determine studies that reported prevalence of fracture in thalassemia patients. The pooled prevalence with 95% confidence interval (95%CI) of fracture across studies was determined using a random-effect, generic inverse variance method.
After two rounds of systematic review, a total of 25 studies with 4934 patients were included in the meta-analysis. The pooled prevalence of fracture among patients with thalassemia was 16% (95%CI, 15-17%, I = 94.3%). The subgroup analyses showed that the pooled prevalence of fracture was 4% (95%CI, 2-6%; I = 70.4%) among patients with alpha thalassemia, 17% (95%CI, 16-19%; I = 93.2%) among patients with beta thalassemia, 18% (95%CI, 16-19%; I = 89.0%) among patients with transfusion-dependent thalassemia, and 7% (95%CI, 4-10%; I = 94.2%) among patients with non-transfusion-dependent thalassemia.
Fracture is common in patients with thalassemia, and may be more prevalent in beta thalassemia and transfusion-dependent thalassemia than in alpha thalassemia and non-transfusion-dependent thalassemia.
多项观察性研究报告称,地中海贫血患者骨折的发生率较高。然而,这些研究大多纳入的患者数量有限,只有少数研究报告了不同类型和严重程度的地中海贫血患者的骨折发生率。
本系统评价和荟萃分析旨在总结所有关于地中海贫血患者骨折发生率的现有数据。
通过系统检索 EMBASE 和 MEDLINE 数据库,从建库至 2021 年 6 月,确定了报告地中海贫血患者骨折发生率的研究。采用随机效应、通用逆方差法,确定研究间骨折总发生率及其 95%置信区间(95%CI)。
经过两轮系统评价,共有 25 项研究、4934 例患者纳入荟萃分析。地中海贫血患者的骨折总发生率为 16%(95%CI,15-17%,I = 94.3%)。亚组分析显示,α地中海贫血患者的骨折发生率为 4%(95%CI,2-6%,I = 70.4%),β地中海贫血患者为 17%(95%CI,16-19%,I = 93.2%),输血依赖型地中海贫血患者为 18%(95%CI,16-19%,I = 89.0%),非输血依赖型地中海贫血患者为 7%(95%CI,4-10%,I = 94.2%)。
骨折在地中海贫血患者中较为常见,β地中海贫血和输血依赖型地中海贫血患者的骨折发生率可能高于α地中海贫血和非输血依赖型地中海贫血患者。